Clinical Trials Browser

INDUSTRY × Advanced Non-small Cell Lung Cancer × Clear all

NCT05099172 2026-03-12

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

Phase 1/2 Active not recruiting

370 enrolled 1 FDA

Advanced Non-small Cell Lung Cancer

NCT06452277 2026-03-02

SOHO-02

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

NCT06269133 2025-08-27

Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients

Active not recruiting

Advanced Non-small Cell Lung Cancer

NCT02582125 2025-03-24

ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Advanced Non-small Cell Lung Cancer

NCT05215067 2025-03-12

A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer

Phase 2 Active not recruiting

Advanced Non-small Cell Lung Cancer

NCT06868732 2025-03-11

Evaluation of JSKN016 Combination Therapy in Subjects with NSCLC

Phase 1 Not yet recruiting

Advanced Non-small Cell Lung Cancer

NCT06823245 2025-02-12

Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function

Phase 1 Not yet recruiting

Advanced Non-small Cell Lung Cancer

NCT06775483 2025-01-15

Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study

Phase 2 Not yet recruiting

Advanced Non-small Cell Lung Cancer

NCT02108964 2024-12-11

A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies

Phase 1/2 Completed

225 enrolled 31 charts

Advanced Non-small Cell Lung Cancer

NCT06585059 2024-09-05

Clinical Trial of TQB2928 in Combination With a Third-Generation Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Non-Small Cell Lung Cancers

Phase 1 Not yet recruiting

Advanced Non-small Cell Lung Cancer

NCT06329895 2024-07-05

A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants

Phase 1 Completed

Advanced Non-small Cell Lung Cancer

NCT06378658 2024-07-05

A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants

Phase 1 Completed

Advanced Non-small Cell Lung Cancer

NCT06360211 2024-07-03

A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants

Phase 1 Completed

Advanced Non-small Cell Lung Cancer

NCT06221475 2024-06-28

A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Phase 1 Completed

Advanced Non-small Cell Lung Cancer

NCT04818333 2024-06-13

A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer

Phase 1/2 Active not recruiting

Advanced Non-small Cell Lung Cancer

NCT06434103 2024-05-30

Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC

Phase 1/2 Not yet recruiting

Advanced Non-small Cell Lung Cancer

NCT05420220 2024-05-01

Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

Advanced Non-small Cell Lung Cancer

NCT05482568 2023-10-16

A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer

Phase 1/2 Unknown

Advanced Non-small Cell Lung Cancer

NCT05001724 2023-04-25

KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent

Phase 2/3 Terminated

Advanced Non-small Cell Lung Cancer

NCT03693547 2023-01-10

Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

Phase 2 Completed

Advanced Non-small Cell Lung Cancer

NCT05416775 2022-08-19

Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

Advanced Non-small Cell Lung Cancer

NCT03856697 2019-02-27

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Phase 3 Unknown

Advanced Non-small Cell Lung Cancer